Skip to content

house · Committee report

H. Rept. 118-231

HEALTH CARE PRICE TRANSPARENCY ACT OF 2023

2023-09-29

Committees

Associated legislation

Text

Dissenting Views

[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT] September 29, 2023.--Ordered to be printed 118th Congress } { Rept. 118-231 HOUSE OF REPRESENTATIVES 1st Session } { Part 1 ====================================================================== HEALTH CARE PRICE TRANSPARENCY ACT OF 2023 _______ September 29, 2023.--Ordered to be printed _______ Mr. Smith of Missouri, from the Committee on Ways and Means, submitted the following R E P O R T together with

Dissenting Views

[To accompany H.R. 4822] The Committee on Ways and Means, to whom was referred the bill (H.R. 4822) to improve price transparency with respect to certain health care services, and for other purposes, having considered the same, reports favorably thereon with an amendment and recommends that the bill as amended do pass. CONTENTS Page I. SUMMARY AND BACKGROUND.......................................... 37 A. Purpose and Summary................................. 37 B. Background and Need for Legislation................. 37 C. Legislative History................................. 40 D. Designated Hearing.................................. 40 II. EXPLANATION OF THE BILL......................................... 41 A. Price Transparency Act of 2023...................... 41 III. VOTE OF THE COMMITTEE........................................... 62 IV. BUDGET EFFECTS OF THE BILL...................................... 65 A. Committee Estimate of Budgetary Effects............. 65 B. Statement Regarding New Budget Authority and Tax Expenditures Budget Authority...................... 65 V. OTHER MATTERS TO BE DISCUSSED UNDER THE RULES OF THE HOUSE...... 66 A. Committee Oversight Findings and Recommendations.... 66 B. Statement of General Performance Goals and Objectives......................................... 66 C. Information Relating to Unfunded Mandates........... 66 D. Congressional Earmarks, Limited Tax Benefits, and Limited Tariff Benefits............................ 66 E. Duplication of Federal Programs..................... 66 VI. CHANGES IN EXISTING LAW MADE BY THE BILL, AS REPORTED........... 66 A. Changes in Existing Law Proposed by the Bill, as Reported........................................... 66 VII. DISSENTING VIEWS............................................... 394 The amendment is as follows: Strike all after the enacting clause and insert the following: SECTION 1. SHORT TITLE; TABLE OF CONTENTS. (a) Short Title.--This Act may be cited as the ``Health Care Price Transparency Act of 2023''. (b) Table of Contents.--The table of contents for this Act is as follows: Sec. 1. Short title; table of contents. TITLE I--HEALTH CARE PRICE TRANSPARENCY FOR PATIENTS Sec. 101. Requiring certain facilities under the Medicare program to disclose certain information relating to charges and prices. Sec. 102. Promoting health coverage price transparency. Sec. 103. Oversight of pharmacy benefits manager services. Sec. 104. Reports on health care transparency tools and data requirements. Sec. 105. Report on integration in Medicare. TITLE II--FAIR PRICES FOR PATIENTS Sec. 201. Limitation on cost sharing to net price amount under Medicare part D. Sec. 202. Requiring a separate identification number and an attestation for each off-campus outpatient department of a provider. Sec. 203. Parity in Medicare payments for hospital outpatient department services furnished off-campus. TITLE III--PATIENT-FOCUSED INVESTMENTS Sec. 301. Establishing requirements with respect to the use of prior authorization under Medicare Advantage plans. Sec. 302. Extension of certain direct spending reductions. TITLE I--HEALTH CARE PRICE TRANSPARENCY FOR PATIENTS SEC. 101. REQUIRING CERTAIN FACILITIES UNDER THE MEDICARE PROGRAM TO DISCLOSE CERTAIN INFORMATION RELATING TO CHARGES AND PRICES. (a) In General.--Part E of title XVIII of the Social Security Act (42 U.S.C. 1395x et seq.) is amended by adding at the end the following new section: ``SEC. 1899C. HEALTH CARE PROVIDER PRICE TRANSPARENCY. ``(a) Hospital Price Transparency.-- ``(1) In general.--Beginning January 1, 2026, each specified hospital (as defined in paragraph (6)) that receives payment under this title for furnishing items and services shall comply with the price transparency requirement described in paragraph (2). ``(2) Requirement described.-- ``(A) In general.--For purposes of paragraph (1), the price transparency requirement described in this paragraph is, with respect to a specified hospital, that such hospital, in accordance with a method and format established by the Secretary under subparagraph (C), compile and make public (without subscription and free of charge) for each year-- ``(i) one or more lists, in a format specified by the Secretary (which may be a machine-readable format), of the hospital's standard charges (including the information described in subparagraph (B)) for each item and service furnished by such hospital; and ``(ii) information in a consumer-friendly format (as specified by the Secretary)-- ``(I) on the hospital's prices (including the information described in subparagraph (B)) for as many of the Centers for Medicare & Medicaid Services-specified shoppable services that are furnished by the hospital, and as many additional hospital-selected shoppable services (or all such additional services, if such hospital furnishes fewer than 300 shoppable services) as may be necessary for a combined total of at least 300 shoppable services; and ``(II) that includes, with respect to each Centers for Medicare & Medicaid Services-specified shoppable service that is not furnished by the hospital, an indication that such service is not so furnished. ``(B) Information described.--For purposes of subparagraph (A), the information described in this subparagraph is, with respect to standard charges and prices (as applicable) made public by a specified hospital, the following: ``(i) A description of each item or service, accompanied by, as applicable, the Healthcare Common Procedure Coding System code, the diagnosis-related group, the national drug code, or other identifier used or approved by the Centers for Medicare & Medicaid Services. ``(ii) The gross charge, expressed as a dollar amount, for each such item or service, when provided in, as applicable, the inpatient setting and outpatient department setting. ``(iii) The discounted cash price, expressed as a dollar amount, for each such item or service when provided in, as applicable, the inpatient setting and outpatient department setting (or, in the case no discounted cash price is available for an item or service, the median price charged by the hospital for such item or service when provided in such settings for the previous three years, expressed as a dollar amount). ``(iv) Any other information the Secretary may require for purposes of promoting public awareness of specified hospital standard charges or prices in advance of receiving an item or service from such a hospital, except information that is duplicative of any other reporting requirement under this section. Such information may include any current payer- specific negotiated charges, clearly associated with the name of the third party payer and plan and expressed as a dollar amount, that apply to each such item or service when provided in, as applicable, the inpatient setting and outpatient department setting. ``(C) Method and format.--Not later than January 1, 2026, the Secretary shall establish one or more methods and formats for specified facilities to use in compiling and making public standard charges and prices (as applicable) pursuant to subparagraph (A). Any such method and format-- ``(i) may be similar to any template made available by the Centers for Medicare & Medicaid Services as of the date of the enactment of this subparagraph; ``(ii) shall meet such standards as determined appropriate by the Secretary in order to ensure the accessibility and usability of such charges and prices; and ``(iii) shall be updated as determined appropriate by the Secretary, in consultation with stakeholders. ``(3) Deemed compliance with shoppable services requirement for hospitals with a price estimator tool.-- ``(A) In general.--With respect to each year until the effective date of regulations implementing the provisions of sections 2799A-1(f) and 2799B-6 of the Public Health Service Act (relating to advanced explanations of benefits), including regulations on establishing data transfer standards to effectuate such provisions, a specified hospital shall be deemed to have complied with the requirement described in paragraph (2)(A)(ii)(I) (relating to shoppable services) if such hospital maintains a price estimator tool described in subparagraph (B). ``(B) Price estimator tool described.--For purposes of subparagraph (A), the price estimator tool described in this subparagraph is, with respect to a specified hospital, a tool that meets the following requirements: ``(i) Such tool allows an individual to immediately obtain a price estimate (taking into account whether such individual is covered under any plan, coverage, or program described in clause (iv)(III)) and the discounted cash price charged by a specified hospital, for each Centers for Medicare & Medicaid Services- specified shoppable service that is furnished by such hospital, and for each additional shoppable service as such hospital may select, such that price estimates are available through such tool for at least 300 shoppable services (or for all such services, if such hospital furnishes fewer than 300 shoppable services). ``(ii) Such tool allows an individual to obtain such an estimate by billing code and by service description. ``(iii) Such tool is prominently displayed on the public internet website of such hospital. ``(iv) Such tool does not require an individual seeking such an estimate to create an account or otherwise input personal information, except that such tool may require that such individual provide information specified by the Secretary, which may include the following: ``(I) The name of such individual. ``(II) The date of birth of such individual. ``(III) In the case such individual is covered under a group health plan, group or individual health insurance coverage, a Federal health care program, or the program established under chapter 89 of title 5, United States Code, an identifying number assigned by such plan, coverage, or program to such individual. ``(IV) In the case of an individual described in subclause (III), an indication as to whether such individual is the primary insured individual under such plan, coverage, or program (and, if such individual is not the primary insured individual, a description of the individual's relationship to such primary insured individual). ``(V) Any other information specified by the Secretary. ``(v) Such tool contains a statement confirming the accuracy and completeness of information presented through such tool as of the date such request is made. ``(vi) Such tool meets any other requirement specified by the Secretary. ``(4) Monitoring compliance.--The Secretary shall, through notice and comment rulemaking and in consultation with the Inspector General of the Department of Health and Human Services, establish a process to monitor compliance with this subsection. Such process shall ensure that each specified hospital's compliance with this subsection is reviewed not less frequently than once every 3 years. ``(5) Enforcement.-- ``(A) In general.--In the case of a specified hospital that fails to comply with the requirements of this subsection-- ``(i) the Secretary shall notify such hospital of such failure not later than 30 days after the date on which the Secretary determines such failure exists; and ``(ii) upon request of the Secretary, the hospital shall submit to the Secretary, not later than 45 days after the date of such request, a corrective action plan to comply with such requirements. ``(B) Civil monetary penalty.-- ``(i) In general.--In addition to any other enforcement actions or penalties that may apply under another provision of law, a specified hospital that has received a notification under subparagraph (A)(i) and fails to comply with the requirements of this subsection by the date that is 90 days after such notification (or, in the case of such a hospital that has submitted a corrective action plan described in subparagraph (A)(ii) in response to a request so described, by the date that is 90 days after the Secretary identifies the failure of such hospital to satisfactorily complete such corrective action plan) shall be subject to a civil monetary penalty of an amount specified by the Secretary for each subsequent day during which such failure is ongoing. Such amount shall not exceed-- ``(I) in the case of a specified hospital that is a hospital or critical access hospital with 30 or fewer beds, $300 per day; and ``(II) in the case of any specified hospital and except as provided in clause (iii), $2,000,000 for a 1-year period. ``(ii) Increase authority.--In applying this subparagraph with respect to violations occurring in 2029 or a subsequent year, the Secretary may through notice and comment rulemaking increase-- ``(I) the limitation on the per day amount of any penalty applicable to a specified hospital that is a hospital or critical access hospital with 30 or fewer beds under clause (i)(I); ``(II) the limitation on the amount of any penalty applicable for a 1-year period under clause (i)(II); and ``(III) the limitation on the increase of any penalty applied under clause (iii). ``(iii) Persistent noncompliance.--In the case of a specified hospital (other than a specified hospital that is a hospital or critical access hospital with 30 or fewer beds) that the Secretary has determined to be knowingly and willfully noncompliant with the provisions of this subsection two or more times during a 1-year period, the Secretary may increase any p

Background

H.R. 4822 was introduced on July 24, 2023, and was referred to the Committee on Energy and Commerce, the Committee on Ways and Means, the Committee on Education and Workforce, and the Committee on the Budget. Committee Hearings On Tuesday, May 16, the Committee held a full Committee Hearing, ``Health Care Price Transparency: A Patient's Right to Know.'' On Wednesday, May 17, the Committee held a Health Sub- Committee Hearing, ``Why Health Care is Unaffordable: Anticompetitive and Consolidated Markets.''

Committee Action

The Committee on Ways and Means marked up H.R. 4822, the ``Price Transparency Act of 2023,'' on July 26, 2023, and ordered the bill, as amended, favorably reported (with a quorum being present). D. Designated Hearing Pursuant to clause 3(c)(6) of rule XIII, the following hearings were used to develop and consider H.R. 4822: (1) Committee on Ways and Means Full Committee Hearing ``Health Care Price Transparency: A Patient's Right to Know.'' (2) Committee on Ways and Means Health Sub-Committee Hearing, ``Why Health Care is Unaffordable: Anticompetitive and Consolidated Markets.'' II. EXPLANATION OF THE BILL A. Price Transparency Act of 2023 PRESENT LAW Section 101 Hospital Price Transparency Under the Trump hospital price transparency rule promulgated pursuant to Sec. 2718(e) of the PHSA, hospitals are required to publish prices of medical services in two formats. The first is a machine-readable file containing the following information related to prices for services: gross prices, cash prices, payer-specific negotiated rates, and the de-identified maximum and minimum negotiated rates. The second format is a consumer-friendly display of prices for at least 300 shoppable services. A hospital may provide an online price estimator tool in lieu of publishing prices in the second, consumer-friendly format. CMS will send noncompliant hospitals a written warning notice detailing the specific violation(s). Generally, if noncompliance continues after the notice, CMS will request that the hospital submit a corrective action plan (CAP) within 45 days of the request, which must be completed within 90 days. If noncompliance persists, or if a hospital fails to submit a CAP within 45 days or fails to comply within 90 days of submitting its CAP, CMS may impose a civil monetary penalty (CMP). The CMP amounts, initially $300 per day of noncompliance, are currently tied to a hospital's bed count. For hospitals with 30 or fewer beds, the maximum daily CMP is $300, for a maximum calendar year CMP of $109,500. For hospitals with 31-550 beds, the maximum daily CMP is $10 per bed per day, a range of $310- $5,500. This provides for a maximum calendar year CMP between $113,150 and $2,007,500. For hospitals with 550 or more beds, the maximum daily CMP is $5,500, providing for a maximum calendar year CMP of $2,007,500. Ambulatory Surgical Center Price Transparency Under current law, ambulatory surgical centers are not required to publish their prices. Clinical Laboratory Price Transparency Under current law, clinical laboratories are not required to publish their prices. Imaging Services Price Transparency Under current law, providers of imaging services are not required to publish their prices. Sec. 102 The Department of Health and Human Services is responsible for regulating Medicare Part D Plans. Pharmacy benefits managers (``PBMs'') are third-party administrators that manage prescription drug benefits for Medicare Part D plans. PBMs typically process prescription drug claims, maintain prescription drug formularies on behalf of the plan or issuer, contract with pharmacies for reimbursement, and negotiate prices with drug manufacturers. Although plans and issuers are required to provide certain patient protections as a stipulation of participating in the Medicare Part D prescription drug benefit program\18\ there is currently no Federal law protecting patients from paying more than the negotiated rate during the coverage phase. --------------------------------------------------------------------------- \18\Provide Statute Citation. --------------------------------------------------------------------------- Health Insurer Price Transparency Under the Patient Protection and Affordable Care Act (``PPACA''),\19\ individual market health insurance coverage must meet various requirements to qualify for certification to be offered through an Exchange (``Exchange coverage'').\20\ Among these requirements, Exchange coverage must permit individuals to learn the amount of cost-sharing (including deductibles, copayments, and coinsurance) under the individual's plan or coverage that the individual would be responsible for paying with respect to the furnishing of a specific item or service by a participating provider in a timely manner upon the request of the individual. At a minimum, such information must be made available to such individual through an internet website and such other means for individuals without access to the internet.\21\ This transparency requirement also applies to group health plans and to health insurance issuers offering group or individual health insurance coverage.\22\ --------------------------------------------------------------------------- \19\Pub. L. No. 111-148, March 23, 2010, as amended by the Health Care and Education Reconciliation Act of 2010, Pub. L. No. 111-152, March 30, 2010. \20\An Exchange is established under section 1311 of the PPACA. \21\Sec. 1311(e)(3)(C) of the PPACA. These requirements do not apply to grandfathered coverage as provided under section 1251 of the PPACA. \22\Sec. 2715A of the Public Health Service Act (``PHSA''); sec. 9815. --------------------------------------------------------------------------- In 2020, the Department of the Treasury, the Department of Labor (``DOL''), and the Department of Health and Human Services (``HHS'') (collectively, ``the Departments'') adopted final rules under the authority described above imposing additional transparency requirements on group health plans and issuers of individual and group health insurance coverage,\23\ the Transparency in Coverage Final Rules (``TiC Final Rules'').\24\ The TiC Final Rules require plans and issuers to make the information described below available in the formats described below.\25\ --------------------------------------------------------------------------- \23\The Departments cooperate on implementing analogous requirements applicable to both group health plans and health insurance issuers under their respective authorities. See section 104 of the Health Insurance Portability and Accountability Act (``HIPAA'') of 1996, Pub. L. No. 104-191, August 21, 1996; Notice of Signing of a Memorandum of Understanding among the Department of the Treasury, DOL, and HHS, 64 Fed. Reg. 70164, December 15, 1999. For simplicity, this discussion refers to ``plans and issuers'' when group health plans and issuers of group and individual health insurance coverage are collectively subject to a particular requirement. \24\T.D. 9929, 85 Fed. Reg. 72158, Nov. 12, 2020. \25\These requirements do not apply to health reimbursement arrangements or other account-based plans. --------------------------------------------------------------------------- Self Service Tool Plans and issuers must make available to participants, beneficiaries, and enrollees a ``self-service tool'' that provides estimated cost-sharing information for a covered item or service from a particular provider or providers.\26\ The self-service tool must be available over the internet, and plans and issuers must make the required information available in paper form,\27\ upon request. --------------------------------------------------------------------------- \26\The information made available must include 500 specified items and services for plan years beginning on or after January 1, 2023, and all items and services for plan years beginning on or after January 1, 2024. \27\The TiC Final Rules set forth detailed requirements for the use of the paper method. --------------------------------------------------------------------------- Plans and issuers are required to make the following information available: An estimate of the participant's, beneficiary's, or enrollee's cost-sharing liability for a requested covered item or service;\28\ --------------------------------------------------------------------------- \28\The TiC Final Rules also include detailed provisions regarding the reporting of information on bundled payment arrangements. --------------------------------------------------------------------------- Accumulated amounts;\29\ --------------------------------------------------------------------------- \29\Accumulated amounts are generally defined to mean the amount of financial responsibility a participant, beneficiary, or enroleee has incurred at the time a request for cost-sharing information is made, with respect to a deductible or out-of-pocket limit. --------------------------------------------------------------------------- The in-network rate for the item or service; The out-of-network allowed amount or any other rate that provides a more accurate estimate of an amount the plan or issuer will pay for the requested covered item or service, generally reflected as a dollar amount, if the request for cost-sharing information is for a covered item or service furnished by an out-of-network provider; If applicable, notification that coverage of a specific item or service is subject to a prerequisite; and A notice including specified plain language disclaimers. This information must be made available in plain language, without subscription or other fee, through a self-service tool on an internet website that provides real-time responses based on cost-sharing information that is accurate at the time of the request. The tool must allow users to search for cost-sharing information for a covered item or service provided by a specific in-network provider or by all in-network providers by inputting: A billing code or a descriptive term, at the option of the user; The name of the in-network provider, if the user seeks cost-sharing information with respect to a specific in-network provider; and Other factors utilized by the plan or issuer that are relevant for determining the applicable cost- sharing information (such as location of service, facility name, or dosage). The tool must allow users to search for an out-of-network allowed amount, percentage of billed charges, or other rate that provides a reasonably accurate estimate of the amount a plan or issuer will pay for a covered item or service provided by out-of-network providers by inputting: A billing code or descriptive term, at the option of the user; and Other factors utilized by the plan or issuer that are relevant for determining the applicable out- of-network allowed amount or other rate (such as the location in which the covered item or service will be sought or provided). The tool must allow users to refine and reorder search results based on geographic proximity of in-network providers, and the amount of the participant's, beneficiary's, or enrollee's estimated cost-sharing liability for the covered item or service, to the extent the search for cost-sharing information for covered items or services returns multiple results. The TiC Final Rules also include standards to prevent unnecessary duplication and permit a plan or issuer to satisfy these requirements by entering into a written agreement under which another party provides the required information, though the plan or issuer remains ultimately responsible for providing this information. Machine-Readable Files Plans and issuers must make publicly available three machine-readable files: (1) the in-network rate machine- readable file, which includes including price information for in-network provider rates for covered items and services; (2) the out-of-network allowed amount machine-readable file, which includes information, on out-of-network allowed amounts and billed charges for covered items and services; and (3) the prescription-drug machine readable file, which includes information on negotiated rates and historical net prices for covered prescription drugs. These files must be updated on a monthly basis. The in-network rate machine-readable file must include the following information, with an exception for prescription drugs that are subject to a fee-for-service reimbursement arrangement, in addition to plan or issuer identifying information: A billing code and a plain language description for each billing code for each covered item or service; All applicable rates, including for bundled payment arrangements,\30\ which must be: --------------------------------------------------------------------------- \30\If the plan or issuer does not use negotiated rates for provider reimbursement, then the plan or issuer should disclose derived amounts to the extent these amounts are already calculated in the normal course of business. If the plan or issuer uses underlying fee schedule rates for calculating cost sharing, then the plan or issuer should include the underlying fee schedule rates in addition to the negotiated rate or derived amount. --------------------------------------------------------------------------- Associated with the National Provider Identifier (``NPI''), Taxpayer Identification Number (``TIN''), and Place of Service Code for each in-network provider. Associated with the last date of the contract term or expiration date for each provider-specific applicable rate that applies to each covered item or service; and Indicated with a notation where a reimbursement arrangement other than a standard fee-for-service model (such as capitation or a bundled payment arrangement) applies. The out-of-network allowed amount machine-readable file is required to include, in addition to plan or issuer identifying information: A billing code and a plain language description for each billing code for each covered item or service; and Unique out-of-network allowed amounts and billed charges with respect to covered items or services furnished by out-of-network providers during the 90-day time period that begins 180 days prior to the publication date of the machine-readable file (except that this data must be omitted in relation to a particular item or service and provider when inclusion would require the reporting of out-of-network allowed amounts in connection with fewer than 20 different claims for payments under a single plan or coverage). Each unique out-of-network allowed amount must be reflected as a dollar amount and associated with the NPI, TIN, and Place of Service Code for each out-of- network provider. The prescription drug machine-readable file is required to include, in addition to plan or issuer identifying information: The National Drug Code (``NDC''), and the proprietary and nonproprietary name assigned to the NDC by the Food and Drug Administration (``FDA''), for each covered item or service under each coverage option offered by a plan that is a prescription drug; Negotiated rates, which must be: Reflected as a dollar amount, with respect to each NDC that is furnished by an in-network provider; Associated with the NPI, TIN, and Place of Service Code for each in-network provider; and Associated with the last date of the contract term for each provider-specific negotiated rate that applies to each NDC; and Historical net prices\31\ that are: --------------------------------------------------------------------------- \31\Historical net price means the retrospective average amount a plan or issuer paid for a prescription drug, inclusive of any reasonably allocated rebates, discounts, chargebacks, fees, and any additional price concessions received by the plan or issuer with respect to the prescription drug. --------------------------------------------------------------------------- Reflected as a dollar amount, with respect to each NDC that is furnished by an in-network provider; Associated with the NPI, TIN, and Place of Service Code for each in-network provider; and Associated with the 90-day time period that begins 180 days prior to the publication date of the machine-readable file for each provider-specific historical net price that applies to each NDC (except that such data must be omitted in relation to a particular NDC and provider when inclusion would require the reporting of historical net prices calculated using fewer than 20 different claims for payment). The machine-readable files must be available in a form and manner as specified in guidance issued by the Departments. The machine-readable files must be publicly available and accessible to any person free of charge and without conditions, such as establishment of a user account, password, or other credentials, or submission of personally identifiable information to access the file. The TiC Final Rules include standards to prevent unnecessary duplication and permit plans and issuers to satisfy these requirements by entering into a written agreement under which another party provides the required information, though the plan or issuer remains ultimately responsible for providing this information. In addition, plans and issuers may satisfy the allowed amount file requirement by disclosing out-of-network allowed amounts made available by, or otherwise obtained from, an issuer, a service provider, or other party with which the plan or issuer has entered into a written agreement to provide the information, provided the minimum claim threshold described above is independently met for each item or service and for each plan or coverage included in an aggregated file. Under such circumstances, health insurance issuers, service providers, or other parties with which the plan or issuer has contracted may aggregate out-of-network allowed amounts for more than one plan or insurance policy or contract. Subsequent Changes in Law and Guidance The Consolidated Appropriations Act, 2021 (``2021 CAA''),\32\ also includes transparency requirements. The 2021 CAA requires plans and issuers to offer price comparison guidance by telephone and make available on the plan's or issuer's website a ``price comparison tool'' that (to the extent practicable) allows an individual enrolled under the plan or coverage, with respect to participating providers, to compare the amount of cost

Dissenting Views

Increasing health care consolidation combined with flawed system design and policies that sanction monopolistic behavior is failing patients across the health care system. Prices increase year after year, emergency room wait times lengthen, doctors' offices close, and quality of care suffers. As a long-time advocate for greater transparency, I certainly support the overarching goal of today's markup to ensure more and better data concerning health care prices. Data cannot directly lower costs, but with data we can identify inefficiencies and waste of taxpayer dollars with the potential to lower costs if policymakers show the courage to do it. Unfortunately, what could have been a meaningful, bipartisan product advancing new policies and strengthening prior work has instead become a partisan effort to weaken bipartisan legislation unanimously approved by the Energy and Commerce Committee. This bill largely codifies what is already required of hospitals and some insurers. Meanwhile, some of the worst actors are shielded from any meaningful accountability. Once again, Medicare Advantage is given special treatment, omitted from the transparency requirements of today's legislation. Charging over $1,500 more per person each year than would have otherwise been spent if the patient were in Traditional Medicare, private insurers are making huge profits off MA. This bill continues to advantage private insurance executives over disadvantaged health care consumers and taxpayers. And this legislation completely ignores the growing impact of private equity with its rapid takeover of many health care sectors, often resulting in soaring costs and worsening health inequities. Despite modest, bipartisan, unanimous approval of measures to address both Medicare Advantage and private equity in another committee, today's legislation is silent. Transparency can lead to better oversight, but only if it is targeted toward the right information and the right actors and is paired with enforcement. Unfortunately, this markup misses the mark in addressing these issues and offers very little toward lowering outrageous prices. Nor does this legislation do anything to provide better transparency into the pharmaceutical industry, let alone reduce price gouging or even record the enormous contributions taxpayers make as angel investors in research and development, American taxpayers--the single largest contributors to pharma R&D in the world. We all want to encourage cures and treatments for dreaded diseases long before we or a loved one face a troubling diagnosis. But pharmaceutical monopolies and oligopolies have been more concerned with manipulating the system to delay competitors and extract the highest prices the sick and dying will pay rather than create more innovative treatments. Over a decade (2005-15), 78% of new drug patents were not for the new cures we need, but were small modifications to existing drugs designed to extend monopoly power and monopoly prices. By one new estimate, about $40 billion in taxpayer dollars were wasted in 2019 alone on drugs that violated antitrust laws when delaying competitors. 30% percent of adults report not picking up prescriptions or skipping doses because they could not afford their medications. Yet nothing in this bill concerning Big Pharma. Nothing to help the half of Americans who cannot afford a $500 medical emergency, but will likely be charged thousands if they receive a dreaded diagnosis, suffer a heart attack, or are in a horrific car accident. Unlike shopping for most consumer products, health care is absolutely essential. Patients do not have a choice, yet they are forced to navigate a complex system and are charged outrageous prices by a highly consolidated and broken market. While consumers get sticker shock and medical debt, corporate interests get a shield from meaningful action. Moving forward, we need bipartisan action to lower prices, not just bigger font when prices are disclosed. Sincerely, Lloyd Doggett. [all]

Source: https://api.congress.gov/v3/committee-report/118/hrpt/231